Menu
Annual · values202520242023202220212020
Operating Cash Flow-45.08 M USD-49.96 M USD-62.30 M USD-61.21 M USD-33.30 M USD-12.04 M USD
Depreciation & Amortization1.43 M USD2.11 M USD1.85 M USD1.11 M USD316000 USD157000 USD
Stock-Based Compensation8.13 M USD11.90 M USD13.27 M USD12.26 M USD3.69 M USD448000 USD
Capital Expenditures132000 USD180000 USD1.67 M USD5.35 M USD1.29 M USD120000 USD
Cash Flow from Investing32.15 M USD6.86 M USD-45.78 M USD-5.35 M USD-1.29 M USD13.20 M USD
Cash Flow from Financing5.76 M USD8000 USD44.70 M USD9.14 M USD192.16 M USD13.52 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-45.21 M USD-50.14 M USD-63.98 M USD-66.56 M USD-34.59 M USD-12.16 M USD

Vicarious Surgical Inc. is a pioneering company in the field of medical robotics, dedicated to enhancing surgical procedures through advanced robotic solutions. The company engages in the design and development of proprietary surgical robots integrated with virtual reality technology to offer surgical teams enhanced visualization, precision, and control during minimally invasive surgeries. By leveraging its cutting-edge technology, Vicarious Surgical drives forward the possibilities within the healthcare sector, specifically focusing on improving patient outcomes, reducing recovery times, and increasing the accessibility of complex surgical procedures. The integration of robotics and virtual reality places Vicarious Surgical at the forefront of technological innovation in medicine, illustrating its importance in the ongoing evolution of healthcare practices and methodologies. As a participant in the medical technology ecosystem, Vicarious Surgical Inc. contributes significantly to the innovation landscape, offering solutions that may redefine the very nature of surgical operations across hospitals and clinics globally.